Research from MIT and elsewhere have developed a mobile app that uses computer-vision techniques and AI to detect post-surgery signs of infection as part of an effort to help community workers in Kirehe, a district in Rwanda’s Eastern province, reports Shefali Malhotra for Science. “The researchers are now improving the app so it can be used across more diverse populations such as in Ghana and parts of South America,” writes Malhotra.
Researchers at MIT have developed a new nanoparticle sensor that can detect cancerous proteins through a simple urine test. “The researchers designed the tests to be done on a strip of paper, similar to the at-home COVID tests everyone became familiar with during the pandemic,” writes Lambert. “They hope to make it as affordable and accessible to as many patients as possible.”
Writing for MarketWatch, Joseph Coughlin, director of the MIT AgeLab, discusses the importance of ensuring that retirees have access to quality healthcare. “Given demographic shifts in the medical profession as well as healthcare-industry restructuring, understanding where, and from whom, you will be accessing quality personal care that fits your unique health conditions, just when you most need it most, must now be part of an overall longevity plan that extends well beyond money,” writes Coughlin.
NBC News highlights how researchers from MIT and MGH have developed a new AI tool, called Sybil, that can “accurately predict whether a person will develop lung cancer in the next year 86% to 94% of the time.” NBC News notes that according to experts, the tool "could be a leap forward in the early detection of lung cancer.”
Prof. Marzyeh Ghassemi speaks with WBUR reporter Geoff Brumfiel about her research studying the use of artificial intelligence in healthcare. “When you take state-of-the-art machine learning methods and systems and then evaluate them on different patient groups, they do not perform equally,” says Ghassemi.
Prof. Marzyeh Ghassemi speaks with Scientific American reporter Sara Reardon about the impact of AI chatbots on medical care. “Ghassemi is particularly concerned that chatbots will perpetuate the racism, sexism and other types of prejudice that persist in medicine—and across the Internet,” writes Reardon. “Scrubbing racism from the Internet is impossible, but Ghassemi says developers may be able to do preemptive audits to see where a chatbot gives biased answers and tell it to stop or to identify common biases that pop up in its conversations with users.”
Prof. Amy Finkelstein speaks with Stephen Dubner of Freakonomics Radio about why insurance markets are broken, how they can be fixed, and her new book, “Risky Business.” Finkelstein explains that “one thing I hadn’t realized ‘til I started working in economics is there’s another type of market frailty that’s really important, that’s the subject of a lot of government policy, but that most people just don’t seem to be as aware of. And that’s the problem of selection. And it’s front and center in insurance markets.”
Researchers at MIT developed a system that uses artificial intelligence to help predict future risk of developing breast cancer, reports Poppy Harlow for CNN. What this work does “is identifies risk. It can tell a woman that you’re at high risk for developing breast cancer before you develop breast cancer,” says Larry Norton, medical director of the Lauder Breast Center at the Memorial Sloan Kettering Cancer Center.
Fast Company reporter Amelia Hemphill spotlights the work of Alicia Chong Rodriguez SM ’17, SM ’18, and her startup Bloomer Tech, which is “dedicated to transforming women’s underwear into a healthcare device.” “Our big goal is to generate digital biomarkers,” says Chong Rodriguez. “Digital biomarkers work more like a video, so it will definitely allow a more personalized care from the physician to their patient.”
Writing for Fortune, Prof. Elazer R. Edelman and Mike Mussallem of Edwards Lifesciences write that the backlog of deferred medical treatments caused by the Covid-19 pandemic and resulting long-term health consequences could impact public health for years. Edelman and Mussallem emphasize that “it is incumbent upon us to identify timely real-world evidence to elucidate the effects of policy changes so they can be adaptive and agile enough to provide access to critical interventions and procedures.”
An ingestible, pill-shaped sensor module, which can pinpoint its location as it moves through the body, has been developed by researchers at MIT and Caltech, reports Andrew Paul for Popular Science. This method “could one day offer an effective means to assess issues like constipation, gastroesophageal reflux disease, and gastroparesis,” writes Paul.
A new smart pill the size of a quarter, developed by a team of researchers from MIT, Caltech and NYU, could one day help doctors more easily identify issues in a patient’s digestive tract. “Such a device could offer an alternative to more invasive procedures in humans, such as endoscopy, that are currently used to diagnose motility disorders,” writes Nina Massey for The Independent.
Prof. Gio Traverso and his colleagues at Caltech and NYU have developed a smart ingestible sensor that may offer a less invasive way to diagnose gastrointestinal disorders. “The hope is the device will allow doctors, armed with the exact location of a GI tract disruption, to better target care — and give patients a diagnostic option they can use at home,” reports Lizzy Lawler for STAT.
Researchers from MIT and Caltech have developed a pill-shaped ingestible sensor that can be monitored as it moves through the GI tract, allowing doctors to more easily diagnose gastrointestinal disorders, reports Brian Heater for TechCrunch. “The ability to characterize motility without the need for radiation, or more invasive placement of devices, I think will lower the barrier for people to be evaluated,” says Prof. Giovanni Traverso.
Researchers at MIT and Massachusetts General Hospital have developed “Sybil” – an artificial intelligence tool that can predict the risk of a patient developing lung cancer within six years, reports Mallika Marshall for CBS Boston.